S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Обновления в реальном времени для Pfizer Inc [PFE.DE]

Биржа: XETRA Сектор: Pharmaceuticals Промышленность: Drug Manufacturers—General
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-04-29)

Expected move: +/- 0.00%

Последнее обновление26 апр. 2024 @ 18:35

-0.25% 23.79

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 18:35):

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands...

Stats
Объем за сегодня 70 820.00
Средний объем 92 922.00
Рыночная капитализация 134.31B
EPS €0 ( 2024-01-30 )
Дата следующего отчета о доходах ( €0 ) 2024-04-29
Last Dividend €0.410 ( 2023-07-27 )
Next Dividend €0 ( N/A )
P/E 69.96
ATR14 €0.0470 (0.20%)

Объем Корреляция

Длинно: 0.03 (neutral)
Кратко: 0.59 (weak)
Signal:(51.925) Neutral

Pfizer Inc Корреляция

10 Самые положительные корреляции
10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Pfizer Inc Корреляция - Валюта/Сырье

The country flag 0.07
( neutral )
The country flag -0.04
( neutral )
The country flag 0.00
( neutral )
The country flag 0.03
( neutral )
The country flag -0.07
( neutral )
The country flag -0.17
( neutral )

Pfizer Inc Финансовые показатели

Annual 2023
Выручка: €58.50B
Валовая прибыль: €33.54B (57.34 %)
EPS: €0.380
FY 2023
Выручка: €58.50B
Валовая прибыль: €33.54B (57.34 %)
EPS: €0.380
FY 2022
Выручка: €100.33B
Валовая прибыль: €65.99B (65.77 %)
EPS: €5.63
FY 2021
Выручка: €81.29B
Валовая прибыль: €50.47B (62.08 %)
EPS: €3.95

Financial Reports:

No articles found.

Pfizer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.400
(N/A)
€0.400
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Pfizer Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.07 - average (69.29%) | Divividend Growth Potential Score: 4.08 - Stable (18.42%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.325 2008-01-11
Last Dividend €0.410 2023-07-27
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 68 --
Total Paid Out €20.64 --
Avg. Dividend % Per Year 0.00% --
Score 3.7 --
Div. Sustainability Score 6.07
Div.Growth Potential Score 4.08
Div. Directional Score 5.07 --
Next Divdend (Est)
(2024-07-08)
€0.419 Estimate 22.38 %
Dividend Stability
0.60 Average
Dividend Score
3.70
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
KTF.DE Ex Dividend Knight 2023-06-29 Quarterly 0 0.00%
2GB.DE Ex Dividend Junior 2023-06-14 Annually 0 0.00%
UDC.DE Ex Dividend Junior 2023-07-10 Annually 0 0.00%
ECGF.F Ex Dividend Junior 2023-09-14 Semi-Annually 0 0.00%
NF4.DE No Dividend Player 2023-06-27 Sporadic 0 0.00%
AEC1.DE Ex Dividend Knight 2023-07-06 Quarterly 0 0.00%
XY6.DE Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
GDX.DE Ex Dividend Knight 2023-10-05 Quarterly 0 0.00%
PHM7.DE Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
BFSA.DE Ex Dividend Junior 2023-06-16 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.03671.5009.2710.00[0 - 0.5]
returnOnAssetsTTM0.009471.2009.6810.00[0 - 0.3]
returnOnEquityTTM0.02221.500-0.864-1.296[0.1 - 1]
payoutRatioTTM4.31-1.00010.00-10.00[0 - 1]
currentRatioTTM0.9070.800-0.467-0.373[1 - 3]
quickRatioTTM0.5830.800-1.279-1.023[0.8 - 2.5]
cashRatioTTM0.05971.500-0.779-1.169[0.2 - 2]
debtRatioTTM0.313-1.5004.79-7.18[0 - 0.6]
interestCoverageTTM0.5511.000-0.907-0.907[3 - 30]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
freeCashFlowPerShareTTM0.8562.009.5710.00[0 - 20]
debtEquityRatioTTM0.796-1.5006.82-10.00[0 - 2.5]
grossProfitMarginTTM0.4791.0005.365.36[0.2 - 0.8]
operatingProfitMarginTTM0.02081.000-1.584-1.584[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1231.000-0.429-0.429[0.2 - 2]
assetTurnoverTTM0.2580.800-1.612-1.289[0.5 - 2]
Total Score6.07

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM66.391.0003.390[1 - 100]
returnOnEquityTTM0.02222.50-0.555-1.296[0.1 - 1.5]
freeCashFlowPerShareTTM0.8562.009.7110.00[0 - 30]
dividendYielPercentageTTM6.481.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
payoutRatioTTM4.311.50010.00-10.00[0 - 1]
pegRatioTTM-2.391.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1491.0008.780[0.1 - 0.5]
Total Score4.08

Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа